Supplier
Centers for Pain Control, INC
Centers for Pain Control, INC was paid $8.17M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoCENTERS FOR PAIN CONTROL, INC
LA PORTE, IN 46350
LA PORTE, IN 46350
33aNPI1790920452assigned 12/10/2008
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$8.17M
24GClaims240,742
24DCodes billed60
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in Indiana
Rank by total paid#13 of 560
Median peer was paid$29.96
This provider vs. median272,862×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 68,593 | $289K | |
| 2019 | 38,149 | $928K | |
| 2020 | 24,883 | $893K | |
| 2021 | 23,949 | $1.33M | |
| 2022 | 27,380 | $1.46M | |
| 2023 | 31,260 | $1.70M | |
| 2024incomplete | 26,528 | $1.57M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 45,645 | 38,870 | $2.30M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 28,557 | 23,306 | $865K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 9.8% | 28,004 | 22,755 | $800K |
| 36475 | 8.0% | 2,719 | 1,628 | $658K | |
| 64493 | 4.4% | 8,036 | 5,927 | $358K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.3% | 16,120 | 13,488 | $269K |
| 64635 | 3.2% | 2,615 | 2,018 | $262K | |
| 93971 | 2.9% | 4,203 | 3,297 | $235K | |
| 93970 | 2.8% | 2,437 | 2,221 | $232K | |
| 64483 | 2.6% | 3,827 | 2,576 | $213K | |
| 01938 | 2.3% | 4,753 | 3,194 | $192K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 2.3% | 3,415 | 2,884 | $190K |
48 more codes
| 64494 | 2.3% | 8,041 | $189K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.2% | 13,289 | $178K |
| 64636 | 2.1% | 3,661 | $174K | |
| 64495 | 1.8% | 5,827 | $146K | |
| 98940 | 1.7% | 14,719 | $138K | |
| 99204 | Doctor's office visit, new patient (more involved) | 1.3% | 1,082 | $106K |
| 99203 | Doctor's office visit, new patient (routine) | 1.2% | 2,028 | $99K |
| 36465 | <1% | 92 | $73K | |
| 27096 | <1% | 953 | $57K | |
| 01940 | <1% | 1,135 | $52K | |
| 20610 | <1% | 2,011 | $47K | |
| 97014 | <1% | 10,260 | $44K | |
| 01937 | <1% | 1,184 | $44K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 407 | $41K |
| 64490 | <1% | 851 | $23K | |
| 36471 | <1% | 766 | $21K | |
| 99442 | <1% | 2,954 | $20K | |
| 77002 | <1% | 1,533 | $19K | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 1,373 | $18K |
| 62323 | <1% | 620 | $17K | |
| 01160 | <1% | 214 | $12K | |
| 64491 | <1% | 826 | $12K | |
| 62321 | <1% | 290 | $11K | |
| 01992 | <1% | 186 | $11K | |
| 99152 | <1% | 770 | $10K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,487 | $8K |
| 36470 | <1% | 468 | $7K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 110 | $3K |
| 76942 | <1% | 299 | $3K | |
| 64492 | <1% | 471 | $3K | |
| 01939 | <1% | 55 | $2K | |
| 64633 | <1% | 58 | $2K | |
| 64634 | <1% | 106 | $2K | |
| 20552 | <1% | 46 | $1K | |
| 77003 | <1% | 115 | $1K | |
| 64484 | <1% | 173 | $1K | |
| 36482 | <1% | 28 | $897.22 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 330 | $887.63 |
| 01200 | <1% | 13 | $568.91 | |
| 01942 | <1% | 23 | $391.06 | |
| 20605 | <1% | 18 | $145.28 | |
| 99243 | 0% | 202 | $0.00 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 0% | 331 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 2,500 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 4,519 | $0.00 |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | 0% | 34 | $0.00 |
| G8942 | Functional outcome assessment using a standardized tool is documented within the previous 30 days and a care plan, based on identified deficiencies is documented within two days of the functional outcome assessment | 0% | 755 | $0.00 |
| G8539 | Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment | 0% | 1,198 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPURANIK, UJWALA (ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Interventional Pain Management LLC | La Porte, IN | $445K |
| Interventional Pain Management, LLC | Munster, IN | $418K |
| Interventional Pain Management LLC | Hobart, IN | $393K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.